Synthetic tripeptide (Glu-Asp-Arg) from the Khavinson bioregulator research tradition.
Also known as: EDR · Glu-Asp-Arg
Part of the Neuropeptides & signaling cluster
Overview
Pinealon is a synthetic tripeptide (Glu-Asp-Arg, EDR) from the Khavinson short-peptide bioregulator class. It has been studied for proposed neuroprotective and gene-regulatory effects in mostly Russian laboratory research and is not authorized as a medicine by Health Canada.
Source & context
Biological / chemical source: Synthetic tripeptide (Khavinson short-peptide class)
Primary research or clinical context: Investigational research compound (not authorized by Health Canada)
Short-peptide bioregulator concept
The Khavinson group proposes that very short peptides such as EDR can interact with regulatory DNA regions and influence gene expression. This hypothesis is central to how pinealon is framed in the primary literature.
Evidence status
Reported antihypoxic and neuroprotective findings derive largely from affiliated laboratories and animal models, with limited independent replication. This page describes that research context and offers no medical or dosing advice.
Sequence
One-letter sequence commonly cited for Pinealon (educational; isoforms and modifications may differ):
EDR
Residues plotted ~100° apart around an α-helix — clustering of one color reveals an amphipathic face.
FAQ about Pinealon
What is Pinealon?+
Pinealon is a synthetic tripeptide (Glu-Asp-Arg, EDR) from the Khavinson short-peptide bioregulator class. It has been studied for proposed neuroprotective and gene-regulatory effects in mostly Russian laboratory research and is not authorized as a medicine by Health Canada.
Is Pinealon an approved medicine?+
Pinealon is discussed here as a research / educational topic. Investigational research compound (not authorized by Health Canada). This is not medical advice.
What is the typical length of Pinealon?+
Pinealon is commonly described as approximately 3 amino acids (Research peptide).